← Back to Search

Behavioural Intervention

NeuroGlove for Anxiety and Depression

N/A
Recruiting
Led By Eric Nussbaum, MD
Research Sponsored by NeuroGlove LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Carry an active diagnosis of anxiety and/or depression.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will study how a device called the NeuroGlove can help people with anxiety and depression. 10 people will be enrolled and receive treatment at home.

Who is the study for?
This trial is for adults aged 18 to 85 who have been diagnosed with anxiety and/or depression, which affects their daily life. They must be able to give informed consent themselves without a legal representative.Check my eligibility
What is being tested?
The NeuroGlove is being tested in this study on about 10 people with active symptoms of anxiety and depression. It's a home-based trial where participants use the glove as an intervention for their condition.See study design
What are the potential side effects?
Since the information provided does not specify side effects, it's important for potential participants to ask about possible risks or discomforts associated with using the NeuroGlove during the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with anxiety or depression.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety symptoms using GAD-7
Change in depression symptoms using PHQ-9
Rate of Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: NeuroGlove Treatment ArmExperimental Treatment1 Intervention
Subjects will receive treatment using the NeuroGlove. The treatment regimen at home will include 1 hour of therapy per day (two 30-minute sessions, one using each hand) for 4 weeks.

Find a Location

Who is running the clinical trial?

NeuroGlove LLCLead Sponsor
2 Previous Clinical Trials
19 Total Patients Enrolled
Eric Nussbaum, MDPrincipal InvestigatorNeuroGlove LLC
1 Previous Clinical Trials
6 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively involved in this medical study?

"Affirmative. By consulting clinicaltrials.gov, it is evident that this medical trial has opened up recruitment since September 27th 2023 and was most recently amended on November 3rd of the same year. As of now, 10 people are needed to be recruited from a single site."

Answered by AI

Is enrollment still open for participants in this research initiative?

"Yes, this trial is actively recruiting based on the most recent review of clinicaltrials.gov data. It was posted on September 27th 2023 and modified as recently as November 3rd 2023."

Answered by AI

Am I eligible to join the experiment?

"This research study is in search of 10 volunteers with co-occurring depression and anxiety between 18 - 85 years old."

Answered by AI

Is the age limit for enrollment in this trial restricted to above 20 years of age?

"To be eligible for this trial, applicants must fall between 18 and 85 years old. For those outside of this age range, there are 357 studies available to people under the age of 18 and 1315 for patients above 65."

Answered by AI

Who else is applying?

What site did they apply to?
NeuroGlove
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I've tried many drugs and therapies over most of my adult life, and more intently over the past 14 years, to relieve depression and anxiety. I have not yet experienced a marked and sustained improvement in symptoms.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
NeuroGlove Anxiety and Depression Study
2023. "NeuroGlove Anxiety and Depression Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06065787.
~4 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top